Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O0BR
|
||||
Former ID |
DIB003304
|
||||
Drug Name |
Poly-ICR
|
||||
Synonyms |
Poly-ICR (topical, keratosis/genital warts); Poly-ICR (topical, keratosis/genital warts), Akela; Poly-ICR (topical, keratosis/genital warts), Nventa; TLR-3 agonist (topical, acitinic keratosis/genital warts), Nventa; Poly IC-poly-arginine (topical, keratosis/genital warts), Nventa
|
||||
Indication | Keratosis [ICD10:L57.0] | Investigative | [543473] | ||
Company |
Nventa Biopharmaceuticals Corp
|
||||
Target and Pathway | |||||
Target(s) | Toll-like receptor 3 | Target Info | Agonist | [543473] | |
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
Pathway Interaction Database | Endogenous TLR signaling | ||||
Reactome | Ligand-dependent caspase activation | ||||
MyD88-independent TLR3/TLR4 cascade | |||||
Trafficking and processing of endosomal TLR | |||||
RIP-mediated NFkB activation via ZBP1 | |||||
TRIF-mediated programmed cell death | |||||
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |||||
IKK complex recruitment mediated by RIP1 | |||||
TRAF6 mediated induction of TAK1 complex | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.